loader from loading.io

Listener Mailbag: Set Point Theory, Trauma & Metabolism, and Why 1200 Calories Can Still Lead to Weight Gain

Fat Science

Release Date: 12/08/2025

Why GLP-1 Medications Work Even When the Scale Doesn't Move show art Why GLP-1 Medications Work Even When the Scale Doesn't Move

Fat Science

What if the scale isn't moving, but your health is dramatically improving?

If you've ever felt discouraged because the number on the scale won't budge—even on a GLP-1 medication—this episode will change how you think about these drugs. Dr. Cooper breaks down the research showing that the biggest benefits have nothing to do with weight loss. It's all about metabolic health.

This Week on Fat Science

Dr. Emily Cooper, Mark Wright, and Andrea Taylor expl

info_outline
Mailbag: Food Tracking, Mechanical Eating Troubleshooting, COVID & Metabolism, and Metformin + GLP-1 Synergy show art Mailbag: Food Tracking, Mechanical Eating Troubleshooting, COVID & Metabolism, and Metformin + GLP-1 Synergy

Fat Science

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions from California, the UK, France, Washington, Wyoming, and beyond. 

The team breaks down why Dr. Cooper does not recommend calorie tracking (and when limited tracking can make sense), how to build confidence in eating without data, and why “mechanical eating” sometimes needs medical customization—especially for people with slow gut transit or gastroparesis-like symptoms.  info_outline Mailbag: GLP-1 Weight Regain, Meals vs Snacks, and Why Some People Don’t Respond show art Mailbag: GLP-1 Weight Regain, Meals vs Snacks, and Why Some People Don’t Respond

Fat Science

his week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions that get to the heart of metabolic health. The team explains the real difference between meals and snacks, discusses whether GLP-1 medications can be appropriate for children in complex cases, explores why some people appear to be “non-responders” to Wegovy, and breaks down why alarming headlines about rapid weight regain miss the bigger metabolic picture. They also explain how to set

info_outline
What the Headlines Get Wrong About GLP-1 Drugs and Metabolism show art What the Headlines Get Wrong About GLP-1 Drugs and Metabolism

Fat Science

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down two GLP-1 studies that challenge a major media myth: GLP-1 medications don’t drive weight loss just because people eat less. Instead, drugs like tirzepatide and semaglutide create direct metabolic shifts—including increased fat oxidation and improved fuel partitioning—regardless of appetite.

The team also explores mechanical eating, the psychological impact of “diet food,” and Andrea’s 13-yea

info_outline
GLP-1 Mailbag: Weight Regain, Leptin Resistance, Hypoglycemia & Why Calories Aren’t the Problem show art GLP-1 Mailbag: Weight Regain, Leptin Resistance, Hypoglycemia & Why Calories Aren’t the Problem

Fat Science

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor tackle a wide-ranging mailbag episode with listener questions from the U.S., UK, and Europe. Topics include unexpected weight regain on GLP-1s, post-meal sleepiness and hypoglycemia, metabolic dysfunction despite normal labs, GLP-1 dosing strategies, and why these medications are about metabolism, not appetite suppression.

Key Questions Answered

More Episodes

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener questions about BMI cutoffs, weight cycling, metabolic adaptation, trauma, GLP-1 differences, and why some people gain weight on ultra-low calories. Dr. Cooper explains what’s really happening inside the metabolic system and why individualized treatment—not dieting—creates sustainable change.

Key Questions Answered

  • If my BMI doesn’t “qualify” for GLP-1s, is Naltrexone + Bupropion helpful—and what labs matter first?
  • Does being overweight always indicate metabolic dysfunction, and why are U.S. rates so high?
  • If diets damage metabolism, what do you do when you’re already 80 pounds overweight?
  • How long does it take for leptin and ghrelin to stabilize with mechanical eating?
  • How can someone gain weight on 1,200 calories/day?
  • After sleeve gastrectomy, how do you eat enough while on a GLP-1?
  • Is set point theory real—and how does the melanocortin pathway influence it?
  • If obesity runs in my family, will I need meds like Zepbound for life?
  • How do trauma and stress alter long-term metabolic health?
  • Can GLP-1s offset weight gain from steroids, mood meds, or hormones?
  • Why might Ozempic work well while Mounjaro causes weight gain?

Key Takeaways

1. BMI rules don’t reflect metabolic truth.
A mid-20s BMI can still mask significant dysfunction, especially with weight cycling.

2. Weight cycling is metabolically stressful.
Repeated losses/regains increase visceral fat, insulin abnormalities, and cardiovascular risk.

3. Obesity is a multi-hormonal disease.
Most people need pharmacology plus sleep, fueling, and movement—not restrictive dieting.

4. Metabolic adaptation is powerful.
Under-fueling lowers thyroid output, suppresses fat-burning, and slows metabolism dramatically.

5. After bariatric surgery or on GLP-1s, frequency matters.
Frequent, nutrient-dense snacks protect muscle, metabolism, and energy.

6. Set point changes with better signaling.
GLP-1s and related therapies help the brain accurately detect weight and lower the defended level.

7. Genetics often mean lifelong support.
Family patterns of obesity usually indicate long-term need for metabolic medication.

8. Trauma amplifies metabolic risk.
Childhood trauma disrupts IGF-1, sleep, stress hormones, insulin, leptin, and ghrelin.

9. Medications can cause weight gain—GLP-1s can help counteract it.
Steroids, mood meds, hormonal agents, and more can be metabolically unfriendly.

10. “Newer” isn’t always better.
Some people respond poorly to the GIP component in Mounjaro/Zepbound. Individual physiology rules.

Dr. Cooper’s Actionable Tips

  • Request deeper evaluation: DEXA, visceral fat, fasting insulin/glucose, leptin, reproductive hormones.
  • Stop restrictive dieting permanently—mechanical eating protects metabolic stability.
  • Work with a fueling-focused dietitian (often ED-trained).
  • Review your medication list for drugs known to cause weight gain.
  • Don’t switch GLP-1s or chase higher doses if your current regimen works.

Notable Quote

“Obesity isn’t a willpower problem. It’s a metabolic disease, and when the underlying system is supported, the body finally has permission to change.” — Dr. Emily Cooper

Links & Resources


Fat Science is your source for breaking diet myths and advancing the science of true metabolic health. No diets, no agendas—just science that makes you feel better. The show is informational only and does not constitute medical advice.